Regeneron Pharmaceuticals total liabilities and share holders equity for the quarter ending December 31, 2024 was $37.759B, a 14.15% increase year-over-year.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2024 was $37.759B, a 14.15% increase from 2023.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2023 was $33.08B, a 13.23% increase from 2022.
Regeneron Pharmaceuticals total liabilities and share holders equity for 2022 was $29.215B, a 14.86% increase from 2021.
Regeneron Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | REGN